alluvipeptides145404 - Profile

About me

Profile

Alluvi, previously BI 4744, represents a promising development in obesity care. This dual activator targeting both GLP-1 and glucose-dependent insulinotropic polypeptide targets demonstrates

https://alluvi-research.co.uk/